In an announcement dated October 19, 2026, Ultima Genomics said its UG200 Sequencing Platform has been selected to power a large-scale single-cell immune profiling study with IMU Biosciences and UK Biobank, covering an initial 80,000 blood samples from UK Biobank participants and producing a foundational immune dataset intended for AI research. Study Design and Participating Platforms IMU Biosciences announced the collaboration from London the same day, naming UK Biobank, Waters Corporation and…
This article has been indexed from Unite.AI
Read the original article: